These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31868550)

  • 21. Evaluating the Effects of Oral and Topical Simvastatin in the Treatment of Acne Vulgaris: A Double-blind, Randomized, Placebo-controlled Clinical Trial.
    Ahmadvand A; Yazdanfar A; Yasrebifar F; Mohammadi Y; Mahjub R; Mehrpooya M
    Curr Clin Pharmacol; 2018; 13(4):279-283. PubMed ID: 30129417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D.
    Agak GW; Qin M; Nobe J; Kim MH; Krutzik SR; Tristan GR; Elashoff D; Garbán HJ; Kim J
    J Invest Dermatol; 2014 Feb; 134(2):366-373. PubMed ID: 23924903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations among two vitamin D receptor (VDR) gene polymorphisms (ApaI and TaqI) in acne vulgaris: A pilot susceptibility study.
    Swelam MM; El-Barbary RAH; Saudi WM; Fathi MS; Soliman DA; Abd Elrehem HH
    J Cosmet Dermatol; 2019 Aug; 18(4):1113-1120. PubMed ID: 30220112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: What is the role of age?
    Babaeinejad S; Khodaeiani E; Fouladi RF
    J Dermatolog Treat; 2011 Aug; 22(4):206-10. PubMed ID: 20666686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Modified Qufeng Runmian Powder () on Acne Vulgaris with Syndromes of Dampness and Blood Stasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Zhang TB; Bai YP; Yang HY; Liu JL; Cao RQ; Wu ZH; Liu YC
    Chin J Integr Med; 2020 Jul; 26(7):490-496. PubMed ID: 32048170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of serum interleukin-19 in acne vulgaris patients of different clinical severities.
    Saleh HM; Deif MA; El-Husseiny RM
    J Cosmet Dermatol; 2021 Sep; 20(9):3034-3040. PubMed ID: 33538078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
    Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
    J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal and dietary factors in acne vulgaris versus controls.
    Stewart TJ; Bazergy C
    Dermatoendocrinol; 2018; 10(1):e1442160. PubMed ID: 29904568
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of ADMA, IMA, and Vitamin A and E Levels in Patients with Acne Vulgaris.
    Tunçez Akyürek F; Saylam Kurtipek G; Kurku H; Akyurek F; Unlu A; Abusoglu S; Ataseven A
    J Cosmet Dermatol; 2020 Dec; 19(12):3408-3413. PubMed ID: 32623816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary therapies for acne vulgaris.
    Cao H; Yang G; Wang Y; Liu JP; Smith CA; Luo H; Liu Y
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009436. PubMed ID: 25597924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li WA
    Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
    Redmond GP; Olson WH; Lippman JS; Kafrissen ME; Jones TM; Jorizzo JL
    Obstet Gynecol; 1997 Apr; 89(4):615-22. PubMed ID: 9083323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum interleukin-17 as a novel biomarker in patients with acne vulgaris.
    Ebrahim AA; Mustafa AI; El-Abd AM
    J Cosmet Dermatol; 2019 Dec; 18(6):1975-1979. PubMed ID: 30964235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady A; Bennett C; Newton JN; Thomas K; Popescu CM
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002086. PubMed ID: 22895927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twelve-week, multicenter, placebo-controlled, randomized, double-blind, parallel-group, comparative phase II/III study of benzoyl peroxide gel in patients with acne vulgaris: A secondary publication.
    Kawashima M; Sato S; Furukawa F; Matsunaga K; Akamatsu H; Igarashi A; Tsunemi Y; Hayashi N; Yamamoto Y; Nagare T; Katsuramaki T
    J Dermatol; 2017 Jul; 44(7):774-782. PubMed ID: 28295516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
    Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
    Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.